For CBD brands planning past November 12, 2026

A licensed manufacturer for brands whose supplier won't survive H.R. 5371.

November 12, 2026 changes the math for every full-spectrum CBD product on the market. If your contract manufacturer hasn't shown you a documented reformulation plan with lab confirmation, you have a supply-chain problem. We're already on the other side of it.

The compliance cliff is a supplier-survival event

H.R. 5371 caps total THC at 0.4 milligrams per finished container β€” not per serving, not per gummy, per container as the consumer receives it. That's a chemistry change, not a labeling change. Most existing full-spectrum gummies and tinctures cannot meet that bar without reformulation.

Some manufacturers will reformulate. Some will not. Some will fold. Brands sourcing from any of those last two categories lose their supplier between now and November.

The window to qualify a backup supplier β€” sample, validate, transfer formulas, run COAs β€” closes well before the enforcement date. Six-week onboarding queues are already forming for fall.

What Steve's Goods is

A licensed hemp manufacturer in Louisville, Kentucky. Operating since 2016. Approximately 3,700 sq ft. White-label and private-label gummies, tinctures, concentrates, and topicals. Vegan pectin platform. ISO-17025 third-party lab program on every batch.

Federal compliance record Active FTC consent order in good standing (Docket C-4739). Five-plus years of clean federal compliance. Substantiation required on every claim.
Backed by HempData Real-time state-by-state regulatory verification through HempData (separate company, same founder, independent data layer). State compliance claims are backed by live data, not assertions.
COA on every batch GC-MS cannabinoid panel, heavy metals, microbial, full scope. ISO-17025 labs on rotation β€” no single-lab dependence.
Documented compliance binder When your bank, processor, or retail buyer asks how you know you're compliant β€” we hand them a documented proof binder. Most operators can't produce one.

What we're offering brands in your situation

  • White-label and private-label manufacturing starting at 8,000-unit MOQ.
  • 30-day migration path from your current supplier, including formula intake, sample run, and COA validation before any production batch.
  • Compliant-by-design product platforms β€” broad-spectrum gummies with engineered trace, CBD isolate base for higher-dose SKUs, CBN sleep, CBG daytime, vegan pectin across the line.
  • Direct founder access on formulation calls. Steve formulates. There is no account-management buffer between you and the person making the product.

How to know if there's a fit

One 15-minute call. Bring your current SKU list, milligram ranges, monthly volume, and what your current supplier has told you (or hasn't) about November 12. We'll tell you whether your situation is something we can manufacture for, and what the timeline looks like.

This is a capability fit assessment, not a sales call. If we're not a fit we'll say so on the call.

Book a 15-minute capability call

Send your SKU list and we'll come to the call with relevant questions. If you'd rather start with the capability sheet, ask for that instead.

Note on the Farm Bill: H.R. 7567 cleared House Agriculture in April 2026 but does not address finished hemp consumables β€” that jurisdiction sits with House Energy and Commerce, which has not picked it up. Two delay amendments were withdrawn before votes. Senate movement is worth tracking, but the only responsible planning assumption is that November 12 holds as written. If a delay materializes, you'll have a compliant supplier earlier than you needed.